Navigation Links
Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting
Date:4/22/2009

outcome thereof. These statements are based on current expectations and assumptions regarding future events and business performance and involve certain risks and uncertainties that could cause actual results to differ materially. These risks include, but are not limited to, risks associated with the development of SCORPION multispecific therapeutics, the clinical advancement of TRU-016, the company's Wyeth collaboration, including Wyeth's control over development timelines, the risks that the Company is unable to advance its clinical development programs and regulatory applications and action at the rate it expects, and such other risks as identified in the company's annual report on Form 10-K for the period ended December 31, 2008, and from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com. Trubion undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

    Contact:
    Jim DeNike
    Senior Director, Corporate Communications
    Trubion Pharmaceuticals, Inc.
    (206) 838-0500
    jdenike@trubion.com
   http://www.trubion.com

    Waggener Edstrom Worldwide Healthcare
    Amy Petty
    Senior Account Executive
    (617) 576-5788
    amyp@waggeneredstrom.com

TRBN-SCORP


'/>"/>
SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
2. Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring
3. Trubion Announces Presentations at Upcoming Investor Conferences
4. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
5. Trubion Announces Presentations at Upcoming Investor Conferences
6. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
7. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
8. Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York
9. Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference
10. Trubion Announces Presentations at April/May Investor Conferences
11. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Patheon Inc ., a ... the global pharmaceutical industry, will host a complimentary webinar ... Testing” on Tuesday, June 4, 2013 at 11 a.m. ... required to comply with regulations for cleaning validation. ... scientific underpinning and little evaluation of risk. Some ...
(Date:5/23/2013)...  Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., ... banking and therapeutics, announced today that StemCyte has become ... Indy car driven by James Jakes ... IndyCar 2013 season.   StemCyte, Inc. and Rahal ... of umbilical cord blood banking and its educational initiative ...
(Date:5/23/2013)... Auburn, MA (PRWEB) May 23, 2013 ... one inch wide and provide 15 mm travel ... nanometers. The small dimensions make these new ... in confined spaces. A vacuum rated version is ... Datasheet:, Drawings, specifications and datasheets can be found ...
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
Breaking Biology Technology:Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3
... Mass., Sept. 4 Hologic, Inc.,(Nasdaq: HOLX ) ... presenting at the Morgan Stanley Global Healthcare Unplugged,Conference being ... in New,York, NY., Interested parties are invited to ... on Tuesday, September 9, 2008, at 1:35 PM.,Eastern Time ...
... InVitria,( http://www.invitria.com ), a leading ... enhance productivity, safety and time to ... culture, life science research and,diagnostics industry, ... 4th Annual "Optimizing Cell Culture Development" ...
... Second Round of Funding Supports Commercialization of Recently FDA-cleared ... Pathwork(R) Tissue of ... a,molecular diagnostics company focused on oncology, announced the closing,today of ... the heels of FDA,s clearance for the Pathwork(R) Tissue of ...
Cached Biology Technology:Hologic to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2InVitria Sponsors Cambridge Healthtech's Optimizing Cell Culture Development Conference 2Pathwork Diagnostics Closes $20M Financing 2
(Date:5/23/2013)... and fastest growing open-access publishers, announces the launch ... and Biotechnology . , A broad scope ... and Biotechnology will provide a single open-access ... research to be disseminated and discussed. , ... provide an open-science and interactive web platform for ...
(Date:5/22/2013)... (NLST) investigators also conclude that the 20 percent ... tomography (LDCT) versus chest X-ray (CXR) screening previously ... at experienced screening centers in the United States. ... with their patients about the benefits and risks ... in the New England Journal of Medicine ...
(Date:5/22/2013)... 2013)The omega 3 fatty acids in fish oil have ... so that the American Heart Association currently recommends eating ... fatty varieties rich in omega 3s. However, the mechanism ... a new study, scientists led by Jason R. Carter ... by providing evidence that fish oil might specifically counteract ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in Bioengineering and Biotechnology 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3Fish oil may help the heart beat mental stress 2
... are eating their way through our national forests, destroying ... If enforcement efforts to prevent their importation aren,t stepped ... can expect to fork over billions of dollars by ... BioScience . Researchers at the University of ...
... found aboard the RMS Titanic, which is contributing to ... threat to the exterior of ships and underwater metal ... report their findings in the latest issue of the ... published on 8 December, isolated the micro-organisms from a ...
... a feature unique to humans and pets. Scientists at ... brown trout have individual characters and show different personalities. ... at the University of Gothenburg has for many years ... the west coast of Sweden. "My results show ...
Cached Biology News:Ravenous foreign pests threaten national treasures 2New microscopic life aboard the RMS Titanic 2
... GenoStat Inducible Expression System provides tightly regulated ... cells and is capable of repeated on/off ... mediated by the highly specific interaction between ... nuclear receptor complex. Gene expression levels are ...
... is extensively scrutinized, including negative ... All horses are of U.S. ... are controlled and documented to ... Pricing: $12/unit for ...
... sets added in Dec 2005 , ... , Detection from as little as 25 ... primers available for hundreds of mammalian miRNAs ... RT-PCR , Ideal for validating expression ...
jub, ajuba homolog (Xenopus laevis)...
Biology Products: